Kostev K. et al.
International Journal of Clinical Pharmacology and Therapeutics
Aim of this study was to show the negative consequences of rebate contracts on health care of patients with depression. Negative consequences were defined as therapy withdrawal, increased resource utilization and the frequency of switch-back to initial pharmaceutical product in patients with conversion to a rebate pharmaceutical.
» Publication sur les problèmes de soins lors d’une dépression (angl.) (PDF, 258 KB)